Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
Interest Income Expense
Creo Medical Group PLC
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Creo Medical Group PLC
LSE:CREO
|
Interest Income Expense
-£182k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Smith & Nephew PLC
LSE:SN
|
Interest Income Expense
-$98m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Interest Income Expense
-$35.6m
|
CAGR 3-Years
17%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Interest Income Expense
-$120.1m
|
CAGR 3-Years
-180%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Interest Income Expense
£66k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Angle PLC
LSE:AGL
|
Interest Income Expense
-£72k
|
CAGR 3-Years
-87%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Creo Medical Group PLC's Interest Income Expense?
Interest Income Expense
-182k
GBP
Based on the financial report for Dec 31, 2022, Creo Medical Group PLC's Interest Income Expense amounts to -182k GBP.
What is Creo Medical Group PLC's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
41%
Over the last year, the Interest Income Expense growth was 41%.